Forecast of the consequences of the adoption draft bill No. 912246-7 on amendments to the legislation on the circulation of medicines and health care for the Russian pharmaceutical market

Abstract

The article is devoted to assessing the possible consequences of the adoption of Draft Law No. 912246-7 “On amending the Federal Law «On the treatment of medicines” and “On the basics of protecting the health of citizens in the Russian Federation” introduced in the State Duma of the Federal Assembly of the Russian Federation on March 2nd, 2020. Critical review leads the authors to the conclusion that this draft law requires significant revision to the second reading, as it does not address the main issues of countering the monopolization of the pharmacy market and does not contribute to the support of domestic drug manufacturers.